Rocket Pharmaceuticals, Inc. (RCKT) NASDAQ
2.89
-0.13(-4.30%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 390.04M |
| Enterprise Value | 337.36M |
| P/E Ratio | -1.55 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 1.36 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -1.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -0.73 |
| Return On Equity | -0.71 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -11.03M |
| EBITDA | -210.21M |
| Net Income | -223.12M |
| Diluted EPS | -2.01 |
Balance Sheet
| Total Cash | 144.38M |
| Total Cash/Share | 1.29 |
| Total Debt | 24.76M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 6.12 |
| Book Value Per Share | 2.12 |
Price History
| 52-Week Change | 4.33 |
| 52-Week High | 5.45 |
| 52-Week Low | 2.4 |
| Moving Average 50 Days | 3.55 |
| Moving Average 200 Days | 3.57 |
Statistics
| Average Volume | 3.24M |
| Shares Outstanding | 109.19M |
| % Held by Institutions | 87.45 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | January 05, 2018 |
